IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 51.33

Change

+0.91 (+1.80)%

Market Cap

N/A

Volume

0.16M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-25 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

+1.27 (+0.86%)

USD 37.71B
FHLC Fidelity® MSCI Health Care In..

+0.32 (+0.46%)

USD 2.77B
FXH First Trust Health Care AlphaD..

+0.39 (+0.35%)

USD 1.05B
XHE SPDR® S&P Health Care Equipme..

-0.56 (-0.62%)

USD 0.20B
IDNA iShares Genomics Immunology an..

-0.18 (-0.79%)

USD 0.12B
SBIO ALPS Medical Breakthroughs ETF

-0.81 (-2.55%)

USD 0.09B
XHS SPDR® S&P Health Care Service..

+0.41 (+0.42%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.25 (-0.84%)

USD 0.05B
BBP Virtus LifeSci Biotech Product..

-1.01 (-1.61%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

-0.54 (-2.58%)

USD 6.67M

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 10.16 % 0.00 %

-0.13 (-0.46%)

USD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.96% 62% D 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.96% 62% D 82% B
Trailing 12 Months  
Capital Gain -4.69% 24% F 23% F
Dividend Return 0.76% 56% F 10% F
Total Return -3.93% 24% F 20% F
Trailing 5 Years  
Capital Gain 41.76% 52% F 63% D
Dividend Return 5.76% 63% D 14% F
Total Return 47.52% 57% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 5.03% 62% D 50% F
Dividend Return 5.68% 62% D 45% F
Total Return 0.65% 63% D 16% F
Risk Return Profile  
Volatility (Standard Deviation) 21.61% 43% F 50% F
Risk Adjusted Return 26.27% 57% F 40% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.